The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Does omidubicel reduce the rate of GvHD compared to standard cord blood transplantation?

During the 2021 TCT Meetings Digital Experience, the GvHD Hub spoke to Mitchell E. Horwitz, Duke University School of Medicine, Durham, US. We asked, Does omidubicel reduce the rate of GvHD compared to standard cord blood transplantation?

Does omidubicel reduce the rate of GvHD compared to standard cord blood transplantation?

In this video, Horwitz discusses the results from a recent randomized phase III study comparing omidubicel, an ex vivo extended umbilical cord blood graft, to standard umbilical cord blood transplantation.

 

Share:
More about...